NewLink Genetics (NLNK)
Add to Watchlists Create an AlertNLNK Key Stats
| Income Statement | |
| Revenue TTM | 1.518M |
| Revenue Quarterly YoY Growth | -35.88% |
| EPS Diluted TTM | -1.222 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -26.41M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -2627% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 413.52M |
| Enterprise Value | 347.81M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 6.893 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0189 |
| Free Cash Flow | -6.847M |
| Return on Equity | -81.43% |
NLNK News
- NewLink Genetics to Be Added to NASDAQ Biotechnology Index Marketwired May 16
- NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 20... May 16
- NEWLINK GENETICS CORP Files SEC form 8-K, Other Events May 16
- NEWLINK GENETICS CORP Files SEC form 8-K, Change in Directors or Principal Offic... May 14
- 3 Biotech Stocks Spiking With Big Volume May 13
- NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report May 8
- Newlink Genetics (NLNK) Posts Q1 Loss of 33c/Share Street Insider May 6
- NewLink Genetics Corporation Reports First Quarter 2013 Financial Results Marketwired May 6
- NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Co... May 6
- Finding Innovative Drugs that are Genuinely Differentiated and Not an Incrementa... May 1
NLNK Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). NewLink Genetics is up 40.43% over the last year vs S&P 500 Total Return up 27.96%, Sarepta Therapeutics up 729.4%, and Albany Molecular Research up 296.8%.
NLNK Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these NLNK related companies
Pro Ratings for NLNK
Pro Report PDF for NLNK
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download NLNK Pro Report PDF
Pro Strategies Featuring NLNK
Did NewLink Genetics make it into our Pro Portfolio Strategies?
NLNK Profile
Sector: Healthcare
Industry: Biotechnology
Other NLNK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NLNK | 16.15 | +0.11 | +0.69% | 413.52M |
